- Home
- TPST vs YI Comparison
TPST vs YI Comparison
Compare TPST & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- YI
- Stock Information
- Founded
- TPST 2011
- YI 2010
- Country
- TPST United States
- YI China
- Employees
- TPST N/A
- YI N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- TPST Health Care
- YI Consumer Staples
- Exchange
- TPST Nasdaq
- YI Nasdaq
- Market Cap
- TPST 42.3M
- YI 38.1M
- IPO Year
- TPST N/A
- YI N/A
- Fundamental
- Price
- TPST $9.21
- YI $3.80
- Analyst Decision
- TPST Hold
- YI
- Analyst Count
- TPST 3
- YI 0
- Target Price
- TPST $30.00
- YI N/A
- AVG Volume (30 Days)
- TPST 33.2K
- YI 7.6K
- Earning Date
- TPST 11-05-2025
- YI 12-05-2025
- Dividend Yield
- TPST N/A
- YI N/A
- EPS Growth
- TPST N/A
- YI N/A
- EPS
- TPST N/A
- YI N/A
- Revenue
- TPST N/A
- YI $1,979,883,442.00
- Revenue This Year
- TPST N/A
- YI N/A
- Revenue Next Year
- TPST N/A
- YI N/A
- P/E Ratio
- TPST N/A
- YI N/A
- Revenue Growth
- TPST N/A
- YI N/A
- 52 Week Low
- TPST $5.35
- YI $3.69
- 52 Week High
- TPST $13.65
- YI $11.35
- Technical
- Relative Strength Index (RSI)
- TPST 42.88
- YI 26.07
- Support Level
- TPST $8.51
- YI $3.69
- Resistance Level
- TPST $9.75
- YI $4.18
- Average True Range (ATR)
- TPST 0.68
- YI 0.17
- MACD
- TPST -0.09
- YI -0.01
- Stochastic Oscillator
- TPST 33.73
- YI 25.61
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.